MDM2/MDMX inhibition by Sulanemadlin synergizes with anti–Programmed Death 1 Immunotherapy in wild-type p53 tumors
Article in iScience (May 2024)
The most recent citing publications are shown below. View all 113 publications that cite this research output on Dimensions.
Article in iScience (May 2024)
Article in Frontiers in Molecular Biosciences (April 2024)
Article in Blood (March 2024)